đź“‹ FDA Reference

philips lumea ipl

Philips Consumer Lifestyle

Summary: The Philips Lumea IPL is an FDA-cleared device for home-use hair removal. It is primarily used by consumers seeking a non-invasive method to reduce hair growth.

FDA Clearance Information

Pathway 510K
Decision Date December 23, 2025
Product Code OHT
Device Class Class 2
Evidence 419 studies

The Philips Lumea IPL was cleared via the FDA 510(k) pathway on December 23, 2025. Manufactured by Philips Consumer Lifestyle, it is classified as a Class 2 device under product code OHT.

What It Is

The Philips Lumea IPL is a home-use intense pulsed light device designed for hair removal. It works by emitting gentle pulses of light that target hair follicles, leading to a reduction in hair growth over time. The device is designed for ease of use without professional training and incorporates safety features to minimize the risk of skin and eye damage.

Clinical Applications

While primarily marketed for consumer use, the Philips Lumea IPL can be relevant in dermatology and cosmetic practices as an adjunct to professional treatments. It is suitable for individuals seeking a convenient, at-home solution for hair reduction, particularly those with lighter skin tones and darker hair, as these are optimal for IPL efficacy.

Indications for Use

The FDA-cleared indications for the Philips Lumea IPL focus on hair removal. It is intended for individuals looking to reduce unwanted hair growth on various body areas, including the legs, arms, and face, with the convenience of home use.

Practical Considerations

The device is typically handheld and designed for easy operation. It is important to follow the manufacturer's guidelines for skin tone compatibility and usage frequency to ensure safety and effectiveness. Users should avoid using the device on tattoos or dark spots.

Related Literature

The linked study from 2011 reviewed the safety of home-use IPL devices, highlighting the need for these devices to be eye-safe and effective while being cost-efficient. It compared several leading devices, noting the lack of international standards for IPL safety. The study underscored the importance of user precautions to prevent ocular and epidermal damage, a key consideration for home users.

Linked Studies (20)

PubMed • 2025

Onyx Liquid Embolic Agent: Basic Knowledge for Its Use in Interventional Neuroradiology.

Journal of neuroendovascular therapy

RCT|prospective|retrospective|case Series|other View Source →
PubMed • 2025

Performance evaluation of quantitative hemoglobin A2 and fetal hemoglobin testing using commercially lyophilized vs. in-house whole blood controls in Chinese clinical laboratories: a 12-year analysis of National External Quality Assessment Data.

Clinical chemistry and laboratory medicine

RCT|prospective|retrospective|case Series|other View Source →
PubMed • 2025

Clinical progress note: Haemophilus influenzae type b.

Journal of hospital medicine

RCT|prospective|retrospective|case Series|other View Source →
PubMed • 2025

Pilot study of social media promotion of home-based self-testing for syphilis.

Sexually transmitted diseases

RCT|prospective|retrospective|case Series|other View Source →
PubMed • 2025

Clinical development and performance of the First to Know Syphilis Self-Test for over-the-counter usage: a de novo rapid test for treponemal antibody.

Journal of clinical microbiology

View Source →
PubMed • 2025

Implementation of an Opt-Out and Rapid Point-of-Care Syphilis Testing Program for Pregnant Patients Presenting to the Emergency Department.

Sexually transmitted diseases

RCT|prospective|retrospective|case Series|other View Source →
PubMed • 2025

Evaluation of Rapid Syphilis Testing Using the Syphilis Health Check in Florida, 2015-2016.

Florida public health review

View Source →
PubMed • 2025

Multiplex droplet digital PCR for the detection and quantitation of Streptococcus pneumoniae, Mycoplasma pneumoniae, and Haemophilus influenzae.

Frontiers in cellular and infection microbiology

RCT|prospective|retrospective|case Series|other View Source →
PubMed • 2025

Palm Multidiagnostic of Mycoplasma pneumoniae, Chlamydia pneumoniae, Haemophilus influenzae, and Streptococcus pneumoniae Using One-Tube CRISPR/Cas12a.

Transboundary and emerging diseases

View Source →
PubMed • 2025

Tp40: a new potential prognostic and diagnostic marker for syphilis.

Microbiology spectrum

View Source →
PubMed • 2025

Serotonin sets up neutrophil extracellular traps to promote neuroendocrine prostate cancer metastasis in the liver.

The Journal of clinical investigation

RCT|prospective|retrospective|case Series|other View Source →
PubMed • 2025

Application value of Philips Ingenuity TF PET/CT scanner imaging agent FAP in evaluating renal fibrosis.

Hellenic journal of nuclear medicine

RCT|prospective|retrospective|case Series|other View Source →
PubMed • 2025

Message from Dr. Philippe T. Georgel, Guest Editor for the Marshall University Collection, Brad D. Smith, President of Marshall University, and Dr. Anivandan Mukherjee, Provost of Marshall University.

Biochemistry and cell biology = Biochimie et biologie cellulaire

View Source →
PubMed • 2025

Editorial - Philippe Ascher (1936-2022).

Neuroscience

View Source →
PubMed • 2025

Improved patient comfort and procedural efficiency using chlorhexidine-coated hydrophilic urethral catheters: a randomized controlled trial.

Journal of Yeungnam medical science

RCT View Source →
PubMed • 2025

pTx-Pulseq in hybrid sequences: Accessible and advanced hybrid open-source MRI sequences on Philips scanners.

Magnetic resonance in medicine

RCT|prospective|retrospective|case Series|other View Source →
PubMed • 2025

Comparative connectomics of Drosophila descending and ascending neurons.

Nature

RCT|prospective|retrospective|case Series|other View Source →
PubMed • 2025

Hydrophilic-coated sheaths for reducing radial artery spasm during transradial procedures: A systematic review and meta-analysis.

Interventional neuroradiology : journal of peritherapeutic neuroradiology, surgical procedures and related neurosciences

View Source →
PubMed • 2025

History of antineutrophil cytoplasmic autoantibodies : Milestones in rheumatology.

Zeitschrift fur Rheumatologie

View Source →
PubMed • 2025

A Hydrophilic Polyurethane Foam Containing Nigella sativa Oil as a Wound Dressing.

BioMed research international

RCT|prospective|retrospective|case Series|other View Source →

Frequently Asked Questions

What is Philips Lumea IPL used for?

The Philips Lumea IPL is used for reducing unwanted hair growth through intense pulsed light technology.

What specialties typically use this device?

Dermatology and cosmetic practices may use IPL devices, though this model is primarily for consumer home use.

What are the FDA-cleared indications?

The device is cleared for hair removal on various body areas, suitable for individuals with lighter skin tones and darker hair.

Disclaimer: This page compiles publicly available regulatory and published clinical evidence for educational reference. It does not constitute medical advice, product endorsement, or a recommendation for clinical use. Always consult manufacturer documentation and clinical judgment for patient care decisions.

📬 Stay Updated

Get the latest vascular education content delivered to your inbox.